Skip to main content
Premium Trial:

Request an Annual Quote

DiaGenic Gets $1.3M Grant for Alzheimer's Dx Project

NEW YORK (GenomeWeb News) – DiaGenic today said that it has received a NOK 7.8 million ($1.3 million) grant from the Norwegian Research Council for an Alzheimer's disease diagnostics program.

The Oslo, Norway-based firm said that the project is aimed at improving the robustness and reducing the cost of blood-based tests for Alzheimer's disease. Specifically, the project will focus on the use of microRNAs for early diagnosis of the disease.

Clinical samples will be sourced from DiaGenic's biobank and the HUNT Biosciences biobank, DiaGenic said.

"This new grant for development of blood based diagnostics for early Alzheimer's disease represents an important financial contribution," DiaGenic CEO Henrik Lund said in a statement.

Two months ago, DiaGenic inked a deal with GE Healthcare to develop a blood-based test using DiaGenic's gene expression profiling tools for the early detection of a disorder associated with Alzheimer's disease.

The Scan

UK Moves to Allow Sale of Gene-Edited Food

The UK is moving ahead to allow the sale of gene-edited food in England, Scotland, and Wales, according to New Scientist.

Questions for the Field

Stat News writes that the alleged Buffalo shooter's citation of genetics research raises questions about what the field can do.

Cell Studies on Tumor Evolution in Mouse Model of Lung Cancer, Stereo-seq, Bacteriophage Responses

In Cell this week: tumor evolution tracked in mouse model of lung cancer, organogenesis mapped using Stereo-seq, and more.

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.